Navigation Links
Global Regulatory and Pharmaceutical Industry Leaders to Appear as Plenary Speakers at Joint FDA-ISPE CGMP Conference
Date:4/11/2012

TAMPA, Fla., April 11, 2012 /PRNewswire-USNewswire/ -- ISPE announced today that it has brought together a substantial line-up of global regulatory officials and pharmaceutical industry leaders to be plenary speakers at the FDA/ISPE co-sponsored "Redefining the 'C' in 'CGMP'" Conference in Baltimore, Maryland, USA on 4 – 5 June 2012. These key regulatory and industry professionals will speak on the key CGMP issues affecting the pharmaceutical industry today. 

(Logo: http://photos.prnewswire.com/prnh/20120208/DC49497LOGO)

"This collaborative FDA-ISPE event is on-track to become a landmark conference with unprecedented opportunities for regulators and industry professionals to engage in dialog, solve problems and learn from one another," said ISPE's President and CEO Nancy Berg. "It's not often that a single conference is able to present this many relevant, high-level speakers. The caliber of these speakers illustrates ISPE's and FDA's shared commitment to addressing quality and manufacturing challenges to ensure the safety and availability of the world's drug supply."

Attendees will receive a rare opportunity to hear directly from the policy makers and influencers affecting business and manufacturing in the 21st century. The plenary sessions will consist of premier presentations focused on global quality, worldwide compliance and the future vision of the pharmaceutical industry.

Plenary speakers at this conference include:

  • Janet Woodcock, Director, Center for Drug Evaluation and Research (CDER), FDA, USA
  • Andy Skibo, Executive Vice President, Operations, MedImmune, USA
  • Deborah Autor, Deputy Commissioner for Global Regulatory Operations and Policy, FDA
  • Ilisa Bernstein, Acting Director, Office of Compliance, CDER, FDA
  • Mary Oates, Vice President of Global Quality Operations, Pfizer, USA
  • Gerald Heddell, Director of Inspection, Enforcement and Standards, MHRA

More information on the Redefining the "C" in "CGMP" Conference, including complete speaker bios, education details and registration information is available at www.ISPE.org/2012CGMPCompliance.

About ISPE
ISPE, the International Society for Pharmaceutical Engineering, is a not-for-profit Society of 22,000 pharmaceutical professionals in 90 countries who use expert knowledge to create high-quality, cost-effective GMP solutions. Founded in 1980, ISPE offers online learning opportunities for a global audience and has its worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; an Asia Pacific office in Singapore; and its newest office in Shanghai, China. Visit www.ISPE.org for additional Society news and information.

For more information contact:
Danielle Hould
ISPE Communications Manager
Tel: +1-813-960-2105, ext. 277
email: dhould@ispe.org
www.ISPE.org  


'/>"/>
SOURCE ISPE
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sustained Growth Forecast for Medical Devices and Drug Delivery Markets According to New Market Research Available from Global Information Inc.
2. MarketsandMarkets: Global Home Healthcare Market Worth $296 Billion by 2016
3. Global BioClinical Launches New Website
4. Global Markets for Catheters
5. Antibody Drugs: Technologies and Global Markets
6. Global Fund Celebrates Efforts of Partners Chevron, The Coca-Cola Company, (RED) and PEPFAR at Capitol Hill Event
7. Magnetic Resonance Imaging (MRI) Market: Global Market Analysis, Size, Share & Forecast (2012 - 2017)
8. HawkPartners/ ICARE Global Patient Pulse Reveals Health Warnings for Some Institutions
9. CooperVision Wins 2012 REBRAND 100® Global Award
10. Pharmaceuticals: Global Industry Guide
11. GlobalSpec Medical Equipment Design Online Trade Show and Event Draws More Than 1,100 Attendees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... While it’s ... poses a problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , ... medication in darkness or restricted lighting. As such, it eliminates the need to turn ...
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... Shelton, CT (PRWEB) , ... October 13, 2017 , ... ... and long-term care services, staged a mock evacuation of the facility as part of ... Department, Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
Breaking Medicine News(10 mins):